01/12/21

Vizient Receives Four-year Accreditation Status in Continuing Education from Joint Accreditation

Vizient received accreditation from Joint Accreditation for Interprofessional Continuing Education, the gold standard in medical continuing education.

More
01/05/21

Vizient Achieves a Microsoft Gold Data Analytics Competency

Vizient attained a gold Data Analytics competency, demonstrating a “best-in-class” ability and commitment to meet Microsoft customers’ evolving needs.

More
12/15/20

Vizient and Sg2 Release Updated Version of COVID-19 Surge Demand Calculator for Hospitals

Vizient, Inc. and its subsidiary company Sg2 today announced the launch of an updated COVID-19 Surge Demand Calculator.

More
12/11/20

Vizient Urges Delay of Most Favored Nation Model for Physician-Administered Drugs

Under the MFN Model, hospitals and certain other health care providers will have their Medicare reimbursement for 50 selected prescription drugs reduced to a rate derived from the lowest amount paid by a comparable foreign nation beginning Jan. 1.

More
12/09/20

COVID’s Effect on Children’s Hospitals, Vaccination Rates Featured in Latest Vizient Pediatric Tech Watch

Vizient, Inc. today released a new Pediatric Tech Watch highlighting the care of pediatric patients in the time of COVID-19.

More
12/04/20

Vizient Offers Comments to FDA on List of Essential Medicines, Medical Countermeasures and Critical Inputs

Vizient submits comments to the FDA applauding its efforts to publish a list of essential medicines, medical countermeasures and critical inputs.

More
12/03/20

Vizient Announces Novaplus Enhanced Supply Agreement with Pfizer for 7 Additional Essential Medications

Vizient announced an agreement with Pfizer to add 7 essential medications to Novaplus Enhanced Supply, Vizient’s private label pharmacy solution.

More
11/23/20

Vizient Analysis Shows Ending Unapproved Drugs Initiative Could Save Between $7.52 Billion and $26.59 Billion

Vizient releases updated analysis showing ending the FDA's Unapproved Drugs Initiative could save hospitals between $7.52 billion and $26.59 billion.

More
11/20/20

Vizient Statement on Access for President-elect Biden’s Transition Team to Information on Federal Efforts in Combating the COVID-19 Pandemic

Vizient issues statement urging access for President-elect Biden's transition team on current efforts and strategy to combat the COVID-19 pandemic.

More
11/19/20

Vizient Announces Novaplus Enhanced Supply Agreement with Fresenius Kabi for 7 Additional Essential Medications

Vizient, Inc. today announced an agreement with Fresenius Kabi to add an additional seven medications to its Novaplus Enhanced Supply program. More